REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroces Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neuroces Sas Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neuroces Sas is based in Colombia. The head office is in Bogota D.C.. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on October 09, 2014. It currently has a total number of 3 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 10.94% in 2023. Its total assets grew by 18.38% over the same period. In 2023, Neuroces Sas’s net profit margin increased by 7.69%.

Headquarters
Carrera 7 # 156 80 Oficina 1104
Bogota D.C.; Bogota D.C; Postal Code: 1007

Contact Details: Purchase the Neuroces Sas report to view the information.

Basic Information
Total Employees:
Purchase the Neuroces Sas report to view the information.
Outstanding Shares:
Purchase the Neuroces Sas report to view the information.
Incorporation Date:
October 09, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Neuroces Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-10.94%
Total operating revenue
-10.94%
Operating profit (EBIT)
-16.24%
Net Profit (Loss) for the Period
40.21%
Total assets
18.38%
Total equity
21.2%
Operating Profit Margin (ROS)
-2.05%
Net Profit Margin
7.69%
Return on Equity (ROE)
2.37%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?